|
SGOL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.605470E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.704500E-02 |
| Normal-vs-Stage2 |
4.062100E-02 |
| Normal-vs-Stage3 |
1.384130E-03 |
| Normal-vs-Stage4 |
1.840770E-04 |
| Stage1-vs-Stage2 |
3.927800E-01 |
| Stage1-vs-Stage3 |
3.656100E-02 |
| Stage1-vs-Stage4 |
1.835930E-03 |
| Stage2-vs-Stage3 |
5.576000E-01 |
| Stage2-vs-Stage4 |
1.674440E-02 |
| Stage3-vs-Stage4 |
3.122300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.0887000000085E-05 |
| Normal-vs-AfricanAmerican |
3.093200E-01 |
| Normal-vs-Asian |
2.816800E-01 |
| Caucasian-vs-AfricanAmerican |
5.422600E-04 |
| Caucasian-vs-Asian |
5.408600E-01 |
| AfricanAmerican-vs-Asian |
3.385400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.64629999999911E-05 |
| Normal-vs-Female |
7.800200E-03 |
| Male-vs-Female |
8.601600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.358400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.604600E-04 |
| Normal-vs-Age(61-80Yrs) |
6.967300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.117600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.002600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.332600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.830400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.032600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.705800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.902000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.697000E-01 |
| Normal-vs-Grade 2 |
1.270200E-02 |
| Normal-vs-Grade 3 |
1.303960E-03 |
| Normal-vs-Grade 4 |
2.004400E-04 |
| Grade 1-vs-Grade 2 |
1.355510E-02 |
| Grade 1-vs-Grade 3 |
3.754700E-04 |
| Grade 1-vs-Grade 4 |
2.208000E-04 |
| Grade 2-vs-Grade 3 |
7.412000E-02 |
| Grade 2-vs-Grade 4 |
1.917540E-03 |
| Grade 3-vs-Grade 4 |
7.584500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.025700E-02 |
| Normal-vs-ccB subtype |
6.49679999999986E-05 |
| ccA subtype-vs-ccB subtype |
3.982800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.985500E-04 |
| Normal-vs-N1 |
7.816400E-03 |
| N0-vs-N1 |
4.457800E-02 |
|
|
